Crescent Medical

Who are Crescent Medical?


Established in 2022 and located in Bolton, Greater Manchester, Crescent Medical is Crescent Pharmaceutical Group's flagship solid dosage manufacturing facility and a key part of the Group's long-term strategy to expand UK manufacturing capability and strengthen supply chain resilience.

The site has been developed to provide large-scale manufacturing of tablets, capsules and liquid medicines, with dedicated infrastructure designed to support the future manufacture and storage of controlled drugs. As investment and regulatory approvals continue, Crescent Medical will significantly enhance the Group's ability to manufacture a wider range of pharmaceutical products in-house, supporting both the UK healthcare market and international growth.
As part of Crescent Pharmaceutical Group's continued investment in UK pharmaceutical manufacturing, Crescent Medical benefits from modern production facilities, advanced manufacturing equipment and scalable infrastructure capable of supporting high-volume commercial production. Together with the Group's wider manufacturing network, the site strengthens Crescent's vertically integrated model, enabling greater control over quality, supply continuity, technical expertise and speed to market.

By increasing in-house manufacturing capacity, Crescent Medical supports the Group's commitment to delivering high-quality, cost-effective generic medicines while reducing reliance on external manufacturing partners and creating a more resilient pharmaceutical supply chain for the future.

Our manufacturing capabilities

Crescent Medical provides established UK pharmaceutical manufacturing capability across solid-dose and liquid medicines, supported by dedicated production, processing and packaging infrastructure.

The Crescent Medical facility spans approximately 80,500 square feet, bringing together dedicated pharmaceutical manufacturing areas, high-speed packaging operations, analytical laboratory facilities, warehousing and supporting office infrastructure.Continued investment in the site has strengthened its manufacturing, packaging and operational capabilities, creating a modern pharmaceutical environment focused on quality, efficiency and reliable production.The facility provides an important platform for the continued expansion of Crescent Pharmaceutical Group’s UK manufacturing capability, increasing capacity and supporting the dependable supply of medicines to the NHS, pharmacies and international markets.

4 x Granulation suites

4 x Blending machines,

7 x Compression suites

1 x Capsule filling machine,

3 x tub/pot filling lines

2 x Coating suites, with capacities of 200kg and 400kg respectively

1 x 1500L vessel dedicated to liquid production

6 x High-speed blister packaging lines, including state-of-the-art machinery such as Bosch, Marchesini Integra, Uhlmann, and Ima.